ACCESS Newswire

ZeptoMetrix, an Antylia Scientific Company

9.4.2024 16:33:56 CEST | ACCESS Newswire | Press release

Share
Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials

TRONDHEIM, NORWAY / ACCESSWIRE / April 9, 2024 / Chiron AS, now part of ZeptoMetrix®, has developed the world's very first commercially available microplastic reference materials. This revolutionary new product range, called MicroPRefs®, was developed in close collaboration with the Norwegian Institute for Water Research (NIVA) and was made possible by grants from the EU project EUROqCHARM and Innovation Norway.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
Chiron by ZeptoMetrix



Microplastic particles are found in large quantities in water, soil, and in the air. Plastic pollution of various kinds breaks down in nature into tiny particles. These range in size from macro- to nano-sized particles. Microplastics are also carriers of various environmental toxins such as PFAS (per- and poly-fluoroalkyl substances) and brominated flame retardants, and cause significant environmental and health risks to communities around the world.

"In order to measure the quantity and type of microplastic substances present, there is a need for a yardstick or a 'reference material,' which is a material developed in the laboratory that can be used for comparison. ZeptoMetrix's Chiron AS business has now developed the very first commercially available microplastic reference materials for the six most abundant plastics in nature. New variants will follow successively throughout this year," stated Huiling Liu, Ph.D., Senior Director, R&D Analytical Reference Materials.

MicroPRefs® microplastic reference materials feature a novel tablet format containing a defined number of particles. The particles produced are of known plastic type and were designed to provide sizes and shapes that mimic microplastics found in nature. The tablets are dissolved in water and then analyzed using various methods and in parallel with real samples from nature.

The first single polymer tablets produced contain microplastic particles ranging in size between 50 and 300 micron. Multi-polymer tablets contain a mixture of three different plastic types. Further variants containing different size, quantity and combinations of plastics are planned to support researchers in their endeavors.

"The need to monitor microplastics in our surroundings is paramount to protecting the ongoing health of our communities. ZeptoMetrix is committed to fostering innovations that will help solve real-world issues as laboratories around the world can now deliver microplastics test results with greater confidence," stated Evangeline Gonzalez, President of ZeptoMetrix. "In addition, our scientists are partnering with industry organizations and leading laboratories to incorporate microplastics into our innovative proficiency testing programs."

About ZeptoMetrix
Chiron AS is part of ZeptoMetrix®, an Antylia Scientific company. ZeptoMetrix is the industry leader and manufacturer for innovative solutions solving challenges in the evolving Diagnostic Microbiology, Infectious Disease, and Oncology markets, as well as Analytical Reference Materials for the Applied Markets. We focus on our customers' success by providing premium product quality, reliability, and expert technical knowledge, enabling our customers to develop and advance many applications across diagnostics, pharmaceutical, environmental, food and beverage industries. From in-stock solutions to custom control and panel development, our scientific teams provide our customers with comprehensive, performance-oriented, and cost-effective products and services that positively impact the field of clinical diagnostics, analytical testing and contribute to a healthier world. ZeptoMetrix is a division of Antylia Scientific, an operating company of premier life science and diagnostic brands, including Cole-Parmer, Environmental Express and ZeptoMetrix.

Contact Information
Nancie Geddings
Global Business Development Leader
nancie.geddings@antylia.com
1-843-277-5230

Related Files

Chiron AS Develops the World's First Commercial Microplastic Reference Materials

SOURCE: ZeptoMetrix

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Proxymity Unveils MiKaDiv Compliance Solution for Issuers Ahead of New German Tax Regime18.11.2026 08:30:00 CET | Press release

FRANKFURT AM MAIN, DE / ACCESS Newswire / November 18, 2026 / Proxymity, the digital investor communications platform, is set to launch its MiKaDiv Compliance Solution as Germany's new dividend reporting regime takes effect in January 2027, giving German issuers a single place to manage their new obligations to the Federal Central Tax Office (BZSt). From 1 January 2027, dividends paid by listed German companies will carry an additional reporting step: the company must pass details of its shareholders to the BZSt. SRD II, transposed into German law under Section 67d of the German Stock Corporation Act, (AktG) took effect in 2020 and gave issuers the right to identify their investors, including foreign investors held through nominee accounts. MiKaDiv now makes it a requirement. The first reports are expected early in the 2027 AGM season, as issuers seek approval for their dividends. Proxymity is the leading provider of shareholder identification to German issuers, handling more than 40%

QorusDocs Named LegalTech AI Platform of the Year and Ranked No. 1 Proposal Management Software17.11.2026 15:00:00 CET | Press release

BELLEVUE, WA / ACCESS Newswire / November 17, 2026 / QorusDocs, the pursuit intelligence platform trusted by dozens of Am Law 200 and Global 200 law firms, today announced it has been named LegalTech AI Platform of the Year in the seventh annual LegalTech Breakthrough Awards program and ranked the No. 1 proposal management solution by Info-Tech Research Group's SoftwareReviews, based on verified end-user reviews. The recognitions cap a year of rapid growth in legal for QorusDocs, which forecasts it will double its annual recurring revenue (ARR) from law firms in the next 12 months by adding more high-profile firms to its list of big law customers, which already includes DLA Piper, Baker McKenzie, Herbert Smith Freehills Kramer and Womble Bond Dickinson. Firms are moving AI beyond research and drafting and into business development, where a winning pitch depends on the best representative matters, strong attorney biographies and winning pitch strategies: knowledge general AI tools lack.

Freezz Italia Awarded ESA Contract for IRIS(2) Low-LEO Pre-Operational and De-Risk Activities17.11.2026 14:00:00 CET | Press release

CORTONA, IT / ACCESS Newswire / November 17, 2026 / Freezz Italia has been awarded a contract by the European Space Agency (ESA), as prime contractor leading a European industrial consortium, for the Consolidation Phase of the IRIS² Low-LEO Pre-Operational and De-Risk Activities, part of the ESA Programme Related to EU Secure Connectivity. The activity will further mature Friisat, Freezz's satellite system architecture conceived specifically for operation in Very Low Earth Orbit (VLEO) and designed for future broadband Direct-to-Device (D2D) connectivity within the 3GPP 5G/6G Non-Terrestrial Network (NTN) framework. Under this ESA contract, Freezz Italia will consolidate the mission and system architecture, adapting Friisat's existing commercial design to meet the requirements of an IRIS²-compatible solution, including future governmental broadband Direct-To-Device secure-connectivity services. The work will address the system and service concepts, architecture and interfaces, security

International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital17.11.2026 11:00:00 CET | Press release

PARIS, FR / ACCESS Newswire / November 17, 2026 / Opti Digital, the leading AdTech company specialising in publisher revenue optimisation, today announced the results of its collaboration with International Business Times UK, an international digital news brand delivering business, markets, technology and current affairs coverage to a global readership. Operating in a fast-moving news environment, International Business Times UK continuously explores opportunities to increase the value of its digital audience while maintaining control over advertising quality and user experience. The publisher identified an opportunity to generate incremental revenue from its existing audience and inventory through a monetisation experience that could be tested progressively and scaled across a broader share of its inventory. "We were looking for ways to generate more value from our existing inventory, and the performance quickly demonstrated the potential of the new experience. It has become a meaning

OBI Pharma Signs Collaboration and License Agreement with Novartis16.11.2026 09:10:00 CET | Press release

TAIPEI, TW / ACCESS Newswire / November 16, 2026 / OBI Pharma, Inc. (4174.TWO) ("OBI") announced that it has entered into a Collaboration and License agreement with Novartis Pharma AG ("Novartis") to develop next generation Antibody-Drug-Conjugates (ADCs) with novel payloads, using OBI's suite of platform technologies. Under the terms of the agreement, Novartis will receive worldwide rights to OBI's related patents and know-how using its ADC platform technologies on an exclusive basis for selected, undisclosed Novartis payload classes. In parallel, under the collaboration OBI will evaluate novellinker approaches with the Novartis payloads. Novartis will further have the option to expand the agreement to include additional novel payload classes. This agreement marks an important milestone for OBI and underscores the value of its differentiated ADC technology platform. The agreement recognizes the potential of OBI's proprietary technologies, including GlycOBI®, EndoSymeOBI®, HYPrOBI®, an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye